Medistim

Report Publication Announcement • Apr 20, 2016

First quarter report for 2016 and presentation for Medistim ASA

First quarter report for 2016 and presentation for Medistim ASA

Sales for the quarter ended at MNOK 65.5 (MNOK 57.9),

an increase of 13.1 %. Currency neutral growth of own

products was 16.6 %. Operating profit (EBIT) ended at

MNOK 13.5 (MNOK 9.9), up 37.2 %. Sales from the US

operation increased with 42.8 % in NOK, while currency

neutral growth was 24.6 %. MiraQ was launched in the

USA during the first quarter. The General Meeting

decided to pay a dividend of NOK 1.65 per share.